A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,605 shares of REGN stock, worth $7.88 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
10,605
Previous 9,559 10.94%
Holding current value
$7.88 Million
Previous $10 Million 10.97%
% of portfolio
0.18%
Previous 0.19%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $1.07 Million - $1.26 Million
1,046 Added 10.94%
10,605 $11.1 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $997,132 - $1.21 Million
1,129 Added 13.39%
9,559 $10 Million
Q1 2024

May 09, 2024

BUY
$902.69 - $993.35 $348,438 - $383,433
386 Added 4.8%
8,430 $8.11 Million
Q4 2023

Feb 07, 2024

BUY
$775.18 - $881.7 $58,138 - $66,127
75 Added 0.94%
8,044 $7.06 Million
Q3 2023

Nov 08, 2023

BUY
$692.45 - $844.37 $560,884 - $683,939
810 Added 11.31%
7,969 $6.56 Million
Q2 2023

Jul 28, 2023

BUY
$700.03 - $830.35 $177,107 - $210,078
253 Added 3.66%
7,159 $5.14 Million
Q1 2023

May 10, 2023

BUY
$680.49 - $826.97 $381,074 - $463,103
560 Added 8.82%
6,906 $5.67 Million
Q4 2022

Feb 10, 2023

BUY
$705.89 - $766.39 $107,295 - $116,491
152 Added 2.45%
6,346 $4.58 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $554,455 - $699,693
966 Added 18.48%
6,194 $4.27 Million
Q2 2022

Aug 09, 2022

BUY
$548.35 - $738.84 $702,436 - $946,454
1,281 Added 32.46%
5,228 $3.09 Million
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $693,909 - $814,369
1,166 Added 41.93%
3,947 $2.76 Million
Q4 2021

Feb 23, 2022

BUY
$543.48 - $670.97 $239,674 - $295,897
441 Added 18.85%
2,781 $1.76 Million
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $264,627 - $313,922
461 Added 24.53%
2,340 $1.42 Million
Q2 2021

Aug 11, 2021

BUY
$472.8 - $558.54 $315,357 - $372,546
667 Added 55.03%
1,879 $1.05 Million
Q1 2021

Apr 28, 2021

BUY
$446.73 - $548.2 $7,147 - $8,771
16 Added 1.34%
1,212 $573,000
Q4 2020

Jan 20, 2021

BUY
$478.3 - $607.98 $572,046 - $727,144
1,196 New
1,196 $578,000
Q4 2020

Jan 19, 2021

SELL
$478.3 - $607.98 $595,005 - $756,327
-1,244 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$544.75 - $658.21 $78,444 - $94,782
144 Added 13.09%
1,244 $696,000
Q2 2020

Jul 27, 2020

BUY
$493.32 - $643.92 $29,105 - $37,991
59 Added 5.67%
1,100 $686,000
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $349,963 - $514,701
1,041 New
1,041 $508,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.